Nasopharyngeal diphtheria

Summary

Nasopharyngeal diphtheria (MONDO:0020866) is a disease. A subtype of nasopharyngeal disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	nasopharyngeal diphtheria
Mondo ID	MONDO:0020866
ICD-10-CM	A36.1
NCIT	C34547
SNOMED CT	75589004
UMLS	C0012558
MedGen	4337
GARD	0025267
Anatomy (UBERON)	UBERON:0001728
Is cancer (heuristic)	no

Also known as: nasopharyngeal diphtheria

Disease family

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › upper respiratory tract disorder › nasopharyngeal disorder › nasopharyngeal diphtheria

Related subtypes (2): nasopharyngitis, nasopharyngeal neoplasm

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.